Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Nov 18, 2022 4:21pm
403 Views
Post# 35111624

RE:RE:RE:Management bought on May 14, Sept. 26 and today

RE:RE:RE:Management bought on May 14, Sept. 26 and todaySome posters on this board complain about a lack of communication from Theralase. But given how Mr. and Mrs. Dumoulin-White have chosen to invest so much of their own money, the message could not be clearer. They seem very confident there will be significant sp appreciation in the near future. The size of their investment suggests they may think of this as the last opportunity to take advantage of the low sp. They can't talk about it, but here actions speak much louder than words.

Rumpl3StiltSkin wrote: Yep Dudes, They seem to be throwing every available financial avenue at these latest PPs...

:-)

enriquesuave wrote:

Yup Roger and wife Kristina bought close to $700 000 worth of stock from both recent PPs.  I don't think they would go that far if they didn't feel comfortable with their investment.  Just IMHO  

 

ScienceFirst wrote:
Management bought on May 14, Sept. 26 and today.

Can't find a better source as a clear signal of what's coming up on many fronts (Ph. 2 data, Breakthrough designation, Accelerated program, COVID-19, NSCLC, GBM).

 

 

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price

 




<< Previous
Bullboard Posts
Next >>